Date: 2016-08-02
Type of information: R&D agreement
Compound: combinations of drugs, growth factors and chemotherapeutic agents
Company: Plasticell (UK) National University of Ireland, Galway (NUI Galway) (Ireland)
Therapeutic area: Cancer - Oncology
Type agreement: R&D -research
Action mechanism:
Disease: leukemia
Details: • On August 2, 2016, Plasticell has announced the signing of a collaboration agreement with the National University of Ireland, Galway (NUI Galway) focused on methods of eradicating cancer stem cells. Plasticell’s proprietary Combinatorial Cell Culture™ (CombiCult®) platform will be used to discover combinations of drugs, growth factors and chemotherapeutic agents that are capable of eradicating cancer stem cells in leukaemia. The work will be carried out at Plasticell and in the laboratory of Dr. Eva Szegezdi at the Apoptosis Research Centre, NUI Galway, and is part funded by an Enterprise Partnership grant from the Irish Research Council.
Financial terms:
Latest news:
